EA199900306A1 - Применение бензопиранолов для лечения неврологических расстройств - Google Patents
Применение бензопиранолов для лечения неврологических расстройствInfo
- Publication number
- EA199900306A1 EA199900306A1 EA199900306A EA199900306A EA199900306A1 EA 199900306 A1 EA199900306 A1 EA 199900306A1 EA 199900306 A EA199900306 A EA 199900306A EA 199900306 A EA199900306 A EA 199900306A EA 199900306 A1 EA199900306 A1 EA 199900306A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- diseases
- benzopiranols
- application
- pain
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010003591 Ataxia Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 208000026072 Motor neurone disease Diseases 0.000 abstract 1
- 208000002740 Muscle Rigidity Diseases 0.000 abstract 1
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 206010043220 Temporomandibular joint syndrome Diseases 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 150000001562 benzopyrans Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000027288 circadian rhythm Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 208000005264 motor neuron disease Diseases 0.000 abstract 1
- 201000003631 narcolepsy Diseases 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000004776 neurological deficiency Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 208000018198 spasticity Diseases 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
- 208000004371 toothache Diseases 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
- 210000003901 trigeminal nerve Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Раскрываются производные и аналоги бензопирана, пригодные для лечения и/или профилактики дегенеративных заболеваний, таких как хорея Гентингтона, шизофрения, связанные со СПИДом неврологические дефициты, нарушения сна (включая нарушения циркадных ритмов, бессонницу и нарколепсию), тики (такие как синдром Жиль де ла Туретта), травматические повреждения головного мозга, шум в ушах, невралгия, особенно тройничного нерва, невропатические боли, зубная боль, боль при злокачественных новообразованиях, неадекватная активность нейронов, проявляющаяся нейродистезией при таких заболеваниях как диабет, PC и заболевание двигательных нейронов, атаксии, мышечная ригидность (спастичность) и дисфункция височно-нижнечелюстного сустава.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
| PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA199900306A1 true EA199900306A1 (ru) | 1999-08-26 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA199900306A EA199900306A1 (ru) | 1996-09-18 | 1997-09-15 | Применение бензопиранолов для лечения неврологических расстройств |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (ru) |
| JP (1) | JP2001500520A (ru) |
| KR (1) | KR20000036184A (ru) |
| CN (1) | CN1230885A (ru) |
| AP (1) | AP9901473A0 (ru) |
| AR (1) | AR008838A1 (ru) |
| AT (1) | ATE270102T1 (ru) |
| AU (1) | AU730465B2 (ru) |
| BG (1) | BG103252A (ru) |
| BR (1) | BR9712030A (ru) |
| CA (1) | CA2266681A1 (ru) |
| DE (1) | DE69729735T2 (ru) |
| DZ (1) | DZ2311A1 (ru) |
| EA (1) | EA199900306A1 (ru) |
| ES (1) | ES2223075T3 (ru) |
| GB (1) | GB9619492D0 (ru) |
| HU (1) | HUP9904638A3 (ru) |
| ID (2) | ID23175A (ru) |
| IL (1) | IL128786A0 (ru) |
| MA (1) | MA24321A1 (ru) |
| NO (1) | NO991292L (ru) |
| NZ (1) | NZ334271A (ru) |
| OA (1) | OA10998A (ru) |
| PE (1) | PE109898A1 (ru) |
| PL (1) | PL332313A1 (ru) |
| SK (1) | SK35199A3 (ru) |
| TR (1) | TR199900527T2 (ru) |
| UY (1) | UY24717A1 (ru) |
| WO (1) | WO1998011890A1 (ru) |
| ZA (1) | ZA978359B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| CA2726874A1 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
| EP2307004A1 (en) * | 2008-06-05 | 2011-04-13 | Minster Research Limited | Novel treatments |
| NZ598942A (en) | 2009-07-27 | 2014-02-28 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| CN102970991A (zh) * | 2009-12-03 | 2013-03-13 | 普罗克西梅根有限公司 | 异常性疼痛和痛觉增敏的治疗 |
| CN102770134A (zh) * | 2009-12-03 | 2012-11-07 | 普罗克西梅根有限公司 | 传染性失调的治疗 |
| CN103096977B (zh) | 2010-07-02 | 2017-02-15 | 吉利德科学公司 | 作为离子通道调节剂的稠杂环化合物 |
| TWI577670B (zh) | 2011-05-10 | 2017-04-11 | 基利科學股份有限公司 | 充當離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (ru) | 2011-07-01 | 2018-04-28 | ||
| TWI622583B (zh) | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
| CN1234702C (zh) * | 1994-06-10 | 2006-01-04 | 史密丝克莱恩比彻姆有限公司 | 苯并吡喃类化合物和包含它们的药物组合物 |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ2311A1 (fr) | 2002-12-28 |
| NZ334271A (en) | 2001-03-30 |
| ZA978359B (en) | 1999-03-17 |
| CA2266681A1 (en) | 1998-03-26 |
| MA24321A1 (fr) | 1998-04-01 |
| ID23175A (id) | 2000-03-23 |
| AP9901473A0 (en) | 1999-03-31 |
| KR20000036184A (ko) | 2000-06-26 |
| PL332313A1 (en) | 1999-08-30 |
| PE109898A1 (es) | 1999-03-21 |
| DE69729735T2 (de) | 2005-07-14 |
| UY24717A1 (es) | 2001-08-27 |
| JP2001500520A (ja) | 2001-01-16 |
| BR9712030A (pt) | 1999-08-24 |
| HUP9904638A3 (en) | 2001-08-28 |
| TR199900527T2 (xx) | 1999-06-21 |
| AU4704797A (en) | 1998-04-14 |
| EP0939630A1 (en) | 1999-09-08 |
| ES2223075T3 (es) | 2005-02-16 |
| AR008838A1 (es) | 2000-02-23 |
| AU730465B2 (en) | 2001-03-08 |
| CN1230885A (zh) | 1999-10-06 |
| GB9619492D0 (en) | 1996-10-30 |
| BG103252A (en) | 1999-09-30 |
| OA10998A (en) | 2003-03-04 |
| IL128786A0 (en) | 2000-01-31 |
| NO991292D0 (no) | 1999-03-17 |
| SK35199A3 (en) | 2000-07-11 |
| WO1998011890A1 (en) | 1998-03-26 |
| HUP9904638A2 (hu) | 2001-05-28 |
| EP0939630B1 (en) | 2004-06-30 |
| ATE270102T1 (de) | 2004-07-15 |
| DE69729735D1 (de) | 2004-08-05 |
| NO991292L (no) | 1999-03-17 |
| ID19542A (id) | 1998-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1014881A4 (en) | TREATMENT OF NEURODEGENERATIVE CONDITIONS BY INFUSION OF NERVOUS GROWTH FACTORS IN THE BRAIN | |
| EA199900306A1 (ru) | Применение бензопиранолов для лечения неврологических расстройств | |
| DE69333874D1 (de) | Verwendung von vier K-252a Derivaten | |
| AU2259292A (en) | Treatment of neuropsychiatric disorders by nerve stimulation | |
| AU2339792A (en) | Treatment of respiratory disorders by nerve stimulation | |
| AU2436397A (en) | Method of treating movement disorders by brain stimulation and drug infusion | |
| ES2082887T3 (es) | Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares. | |
| ATE76294T1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
| AU2399892A (en) | Treatment of anxiety disorders by nerve stimulation | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| WO2000033814A3 (en) | Method for administering agents to the central nervous system | |
| IL129178A0 (en) | Induction of nerve generation | |
| AP2000001832A0 (en) | Substituted isoquinoline derivatives and their use as anticonvulsants. | |
| ATE179700T1 (de) | Tricyclische benzodiazepine, ihr verwendung und herstellung | |
| EP0435177A3 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
| GR3017358T3 (en) | 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants. | |
| ES2104272T3 (es) | Derivados de ciatano y estimuladores de la produccion de factor de crecimiento nervioso y agentes antimicrobianos que los contienen. | |
| HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
| FI952953A0 (fi) | Aineita metabolisten luustosairauksien hoitamiseen | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| Rubin | Imagery in art therapy: The source, the setting, and the significance. | |
| DE3669159D1 (de) | Triazinderivate, verfahren zur herstellung dieser derivate und herbizide, welche diese derivate als wirksame komponente enthalten. | |
| WO2000001440A3 (en) | Methods for treating neurological injuries and disorders | |
| LV5780A4 (lv) | Pretkonvulsiju triazoÚ4,5-c¾piridina atvasinajumi |